Canada markets closed

Hansoh Pharmaceutical Group Company Limited (3KY.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.64000.0000 (0.00%)
At close: 09:15AM CET
Full screen
Previous Close1.6400
Bid1.6600 x N/A
Ask1.7700 x N/A
Day's Range1.6400 - 1.6400
52 Week Range1.1100 - 2.1600
Avg. Volume329
Market Cap10.649B
Beta (5Y Monthly)0.54
PE Ratio (TTM)27.33
EPS (TTM)0.0600
Earnings DateN/A
Forward Dividend & Yield0.01 (0.88%)
Ex-Dividend DateSept 15, 2023
1y Target EstN/A
  • GlobeNewswire

    SCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China

    JERSEY CITY, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China’s National Medical Products Administration (NMPA) has accepted for review a New Drug Application (NDA) for oral ibrexafungerp tablets for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC) in the Chinese mainland.